Da­ta an­a­lyt­ics looms large as Pharm­Stars dig­i­tal health ac­cel­er­a­tor wraps first 'Phar­mU' start­up class

4 years ago
Pharma
Marketing

Can virus-like par­ti­cles un­leash a new wave of CRISPR treat­ments?; Fo­s­un Phar­ma and In­sil­i­co team up in AI dis­cov­ery ...

4 years ago
News Briefing

Ko­re­an con­glom­er­ate SK takes out stake in cell and gene ther­a­py CD­MO with plans for a ma­jor hir­ing spree out­side ...

4 years ago
Cell/Gene Tx
Manufacturing

Pfiz­er's hot start to the new year con­tin­ues with li­cens­ing deal for mys­te­ri­ous biotech's sol­id tu­mor bis­pecifics

4 years ago
Deals

Bob Nelsen, Anne Wo­j­ci­c­ki join $20M round for longevi­ty start­up hop­ing to slow down ag­ing of the ovary

4 years ago
Financing
Startups

Low-pro­file Shang­hai-based CD­MO se­cures high pro­file in­vestors for 9-dig­it Se­ries C

4 years ago
Financing
Manufacturing

Covid-19 roundup: US buys more of the on­ly an­ti­body that works against Omi­cron; BioN­Tech taps AI to de­tect new ...

4 years ago
Coronavirus

Re­call re­port: An­oth­er month, an­oth­er is­sue with ND­MA

4 years ago
Manufacturing

Af­ter a year of big in­vest­ments, Re­ci­pharm sells off as­sets in Eu­rope

4 years ago
Manufacturing

Busy Am­gen swings an­oth­er deal, this time with RNA drug­ging play­er Ar­rakis for 'sev­er­al bil­lion'

4 years ago
Deals

A new AI start­up has emerged, and Pfiz­er likes what it sees

4 years ago
Financing
Startups

Sarep­ta's sec­ond shot at show­ing its Duchenne gene ther­a­py de­liv­ers pos­i­tive da­ta but un­der­whelms — shares tum­ble

4 years ago
R&D
Cell/Gene Tx

In his­toric first, sur­geons trans­plant a ge­net­i­cal­ly mod­i­fied pig heart in­to a dy­ing pa­tient

4 years ago
Discovery

7 block­busters: An­a­lysts spot­light 2022’s crop of drugs most like­ly to win top mar­ket­ing sta­tus — 2 drugs ...

4 years ago
R&D
Pharma

Am­i­cus gets hit with an 'un­ex­pect­ed' set­back on a gene ther­a­py tapped to lead $600M SPAC spin­out

4 years ago
Bioregnum
Cell/Gene Tx

Phar­ma brands spent $3.9B on TV ads in 2021, led by Sanofi, Re­gen­eron’s Dupix­ent and No­vo Nordisk’s Ry­bel­sus

4 years ago
Pharma
Marketing

Health takes cen­ter stage at an­nu­al CES tech bash with ad­vanced wear­ables, tele­health deals and lat­est in Covid ...

4 years ago
Pharma
Marketing

Se­lec­ta turns to syn­bio play­er for $1.1B cap­sid deal; BioN­Tech signs $790M im­munother­a­py deal

4 years ago
News Briefing

No­var­tis snaps up the rights to a Covid-19 an­tivi­ral af­ter see­ing mid-stage re­sults. So where are the da­ta?

4 years ago
Pharma
Coronavirus

Bris­tol My­ers takes a swing at 'off-the-shelf' cell ther­a­pies in $150M cash li­cens­ing pact with Cen­tu­ry

4 years ago
Deals
Cell/Gene Tx

Bris­tol My­ers to spend $50B on deals, buy­backs in next 3 years — al­though BD chief notes find­ing the right deal ...

4 years ago
Deals

Con­tin­u­ing push be­yond Covid-19 vac­cines, Mod­er­na part­ners with 'CAR-M' biotech on in vi­vo can­cer cell ther­a­pies

4 years ago
Deals
Cell/Gene Tx

Make or break for Bio­gen: How the na­tion­al cov­er­age de­ci­sion for amy­loid-tar­get­ed Alzheimer’s drugs will shake out

4 years ago
Pharma

Take­da kicks off JPM week with M&A — buy­ing out an­oth­er gam­ma/delta spin­out and div­ing in­to a new ‘swim lane’

4 years ago
Deals
R&D
First page Previous page 592593594595596597598 Next page Last page
A service from the Financial Times